To analyze patient reported outcomes, safety, and efficacy of the Supris® mid-urethral sling in a diverse population.
A retrospective chart review of 101 women who underwent a mid-urethral Supris® sling procedure was conducted.
Baseline characteristics and peri-operative parameters were collected. Post-operative results and patient reported outcomes were collected at an average follow-up time of 19 months using the Urogenital Distress Inventory-6 (UDI-6) and Patient Global Impression of Improvement (PGI-I) validated questionnaires. Subjective cure rates were compared using the nonparametric Wilcoxon Rank Sum Test.
The median age of women was 57 years old, and 86.1% identified as Latina. 28% and 72% of women had a SUI and MUI diagnosis, respectively. Women, on average, used two pads pre-operatively and none post-operatively. There was a 3% surgical revision rate. 80 women completed the questionnaires. 82% of the MUI group reported being very much improved or much better. The SUI group reported being 94% very much improved or much better. The UDI-6 questions related to urgency and leakage of small amounts of urine were significantly different between the MUI and SUI groups (p = 0.002 and p = 0.044).
In our primarily Latina patient population, the majority of whom had MUI, the Supris® retropubic sling greatly improved symptoms. Although reported outcomes were excellent in both groups, those with pre-operative urge incontinence were more likely to experience urge symptoms post-operatively. Despite persistent urge symptoms, patients reported improvement of their overall symptoms.
Urology. 2021 Oct 09 [Epub ahead of print]
Gabriela Gonzalez, Aman Arora, Eunice Choi, Catherine Bresee, Jonathan Perley, Jennifer T Anger
Department of Urology, University of California, Davis School of Medicine, Sacramento, CA., University of California, Davis School of Medicine, Sacramento, CA., Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA., Department of Statistics, Cedars Sinai Medical Center, Los Angeles, California., California Medical Urology Group, Los Angeles, CA., Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA. Electronic address: .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/34637838